Applications of molecular barcode sequencing for the detection of low‐frequency variants in circulating tumour <scp>DNA</scp> from hepatocellular carcinoma-Reference-Cited by-同舟云学术

Applications of molecular barcode sequencing for the detection of low‐frequency variants in circulating tumour DNA from hepatocellular carcinoma

Published:2022-07-16 Issue:10 Volume:42 Page:2317-2326
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Lee Hye Won¹²³^ORCID,Kim Esl⁴,Cho Kyung Joo³,Park Hye Jung³,Seo Jieun⁵,Lee Hyeonah⁴,Baek Eunha⁶,Choi Jong Rak⁵⁶,Han Kwang‐Hyub³,Lee Seung‐Tae⁵⁶,Park Jun Yong¹²³^ORCID

Affiliation:

1. Department of Internal Medicine Yonsei University College of Medicine Seoul South Korea

2. Institute of Gastroenterology Yonsei University College of Medicine Seoul South Korea

3. Yonsei Liver Center Severance Hospital Seoul South Korea

4. Department of Medical Science The Graduate School, Yonsei University Seoul South Korea

5. Department of Laboratory Medicine Yonsei University College of Medicine Seoul South Korea

6. Dxome Co. Ltd. Seongnam‐si Gyeonggi‐do South Korea

Funder

Gilead Sciences

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15356

Reference51 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. A global view of hepatocellular carcinoma: trends, risk, prevention and management

3. Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?

4. Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area

5. Hepatocellular Carcinoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma;Molecular Cancer;2024-09-06

2. Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments;Gut;2024-07-25

3. Protein induced by vitamin K absence or antagonist II: Experience to date and future directions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Liquid Liver Biopsy for Disease Diagnosis and Prognosis;Journal of Clinical and Translational Hepatology;2023-07-27

5. HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice;Frontiers in Oncology;2022-11-28